| D00094 |
Tretinoin (JAN/USP/INN); Avita (TN); Renova (TN); Retin A (TN); Tretinoin (TN) |
(P) unclassified |
| D00125 |
Etoposide (JP18/USP/INN); Vepesid (TN) |
(P) Target: TOP2A TOP2B |
| D00142 |
Methotrexate (JP18/USP/INN); Otrexup (TN); Xatmep (TN) |
(P) unclassified |
| D00155 |
Pentostatin (JAN/USAN/INN); Nipent (TN) |
(P) unclassified |
| D00161 |
Mercaptopurine (USP); Mercaptopurine hydrate (JP18); Purinethol (TN); Purixan (TN) |
(P) unclassified |
| D00168 |
Cytarabine (JP18/USP/INN); ARA-C; Depocyt (TN) |
(P) unclassified |
| D00208 |
Mitomycin (USP/INN); Mitomycin C (JP18); MMC; Jelmyto (TN); Mitomycin (TN); Muamycin (TN) |
(P) unclassified |
| D00211 |
Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) |
(CI,P) unclassified |
| D00214 |
Dactinomycin (USP); Actinomycin D (JP18); Cosmegen (TN) |
(P) unclassified |
| D00248 |
Busulfan (JP18/USP/INN); Myleran (TN) |
(P) unclassified |
| D00252 |
Carbamazepine (JP18/USP/INN); Equetro (TN); Tegretol (TN) |
(P) unclassified |
| D00254 |
Carmustine (JAN/USP/INN); Bicnu (TN); Gliadel (TN) |
(P) unclassified |
| D00266 |
Chlorambucil (JAN/USP/INN); Leukeran (TN) |
(P) unclassified |
| D00275 |
Cisplatin (JP18/USP/INN); Platinol (TN) |
(P) unclassified |
| D00287 |
Cyclophosphamide (USP); Cyclophosphamide hydrate (JP18); Cytoxan (TN); Neosar (TN) |
(P) unclassified |
| D00288 |
Dacarbazine (JAN/USP/INN); DTIC-Dome (TN) |
(P) unclassified |
| D00323 |
Flucytosine (JP18/USP/INN); Ancobon (TN) |
(P) unclassified |
| D00341 |
Hydroxyurea (USP); Hydroxycarbamide (JAN/INN); Droxia (TN); Hydrea (TN); Siklos (TN) |
(P) unclassified |
| D00343 |
Ifosfamide (JAN/USP/INN); Ifex (TN) |
(P) unclassified |
| D00350 |
Itraconazole (JP18/USP); Itrizole (TN); Sporanox (TN) |
(P) unclassified |
| D00363 |
Lomustine (USP/INN); Gleostine (TN) |
(P) unclassified |
| D00369 |
Melphalan (JP18/USP/INN); Alkeran (TN) |
(P) unclassified |
| D00420 |
Mitotane (JAN/USP/INN); Lysodren (TN) |
(P) unclassified |
| D00467 |
Pipobroman (JAN/USAN/INN); Vercyte (TN) |
(P) unclassified |
| D00468 |
Plicamycin (USAN/INN); Mithracin (TN) |
(P) unclassified |
| D00478 |
Procarbazine hydrochloride (JP18/USP); Matulane (TN) |
(P) unclassified |
| D00491 |
Paclitaxel (JAN/USP/INN); Abraxane (TN); Taxol (TN) |
(P) unclassified |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) unclassified |
| D00567 |
Celecoxib (JP18/USP/INN); Celebrex (TN); Onsenal (TN) |
(P) unclassified |
| D00583 |
Thiotepa (JAN/USP/INN); Thioplex (TN); Tepadina (TN); Rethio (TN) |
(P) unclassified |
| D00584 |
Fluorouracil (JP18/USP/INN); 5-FU (TN); Adrucil (TN); Carac (TN); Fluoroplex (TN) |
(P) unclassified |
| D00753 |
Sirolimus (JAN/USAN/INN); Rapamune (TN); Rapamycin (TN) |
(P) unclassified |
| D00829 |
Eflornithine hydrochloride (USAN); Iwilfin (TN); Vaniqa (TN) |
(P) unclassified |
| D01059 |
Nimustine hydrochloride (JAN); Nidran (TN) |
(P) unclassified |
| D01061 |
Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP18); Irinotecan hydrochloride trihydrate; CPT 11; CPT-11; Campto (TN); Camptosar (TN); Onivyde (TN) |
(P) unclassified |
| D01064 |
Raltitrexed (JAN/USAN/INN); Tomudex (TN) |
(P) unclassified |
| D01068 |
Vinblastine sulfate (JP18/USP); Exal (TN); Velban (TN) |
(P) unclassified |
| D01155 |
Gemcitabine hydrochloride (JAN/USP); Gemzar (TN) |
(P) unclassified |
| D01211 |
Leucovorin calcium (USP); Calcium folinate (JP18); Uzel (TN); Wellcovorin (TN) |
(P) unclassified |
| D01223 |
Capecitabine (JAN/USP/INN); Xeloda (TN) |
(P) unclassified |
| D01244 |
Tegafur (JP18/USAN/INN); Atillon (TN) |
(P) unclassified |
| D01264 |
Daunorubicin hydrochloride (JP18/USP); Cerubidine (TN) |
(P) Target: TOP2A TOP2B |
| D01270 |
Carboquone (JAN/INN); Esquinon (TN) |
(P) unclassified |
| D01275 |
Doxorubicin hydrochloride (JP18/USP); Adriacin (TN); Adriamycin (TN); Doxil (TN); Rubex (TN) |
(P) Target: TOP2A TOP2B |
| D01280 |
Warfarin potassium (JP18); Athrombin-K (TN) |
(P) unclassified |
| D01309 |
Doxifluridine (JP18/INN); Furtulon (TN) |
(P) unclassified |
| D01363 |
Carboplatin (JP18/USP/INN); Paraplatin (TN) |
(P) unclassified |
| D01370 |
Cladribine (JAN/USP/INN); Leustatin (TN); Mavenclad (TN) |
(P) unclassified |
| D01404 |
Sobuzoxane (JAN); Perazolin (TN) |
(P) Target: TOP2A TOP2B |
| D01416 |
Nedaplatin (JAN/INN); Aqupla (TN) |
(P) unclassified |
| D01441 |
Imatinib mesylate (USAN); Imatinib mesilate (JAN); Gleevec (TN); Glivec (TN) |
(P) unclassified |
| D01516 |
Tretinoin tocoferil (JAN); Tocoretinate |
(P) unclassified |
| D01633 |
Enocitabine (JAN/INN); Sunrabin (TN) |
(P) unclassified |
| D01747 |
Idarubicin hydrochloride (JP18/USP); Idamycin (TN) |
(P) Target: TOP2A TOP2B |
| D01760 |
Ranimustine (JAN/INN); Cymerin (TN) |
(P) unclassified |
| D01769 |
Vindesine sulfate (JAN/USAN); Fildesin (TN) |
(P) unclassified |
| D01784 |
Carmofur (JP18/INN); Mifurol (TN) |
(P) unclassified |
| D01790 |
Oxaliplatin (JAN/USP/INN); Eloxatin (TN) |
(P) unclassified |
| D01885 |
Pirarubicin (JP18/INN); Therarubicin (TN) |
(P) Target: TOP2A TOP2B |
| D01907 |
Fludarabine phosphate (JAN/USP); Fludara (TN) |
(P) unclassified |
| D01911 |
Aclarubicin hydrochloride (JP18); Aclacinon (TN) |
(P) Target: TOP2A TOP2B |
| D01935 |
Vinorelbine tartrate (USP); Vinorelbine ditartrate (JAN); KW 2307; Navelbine (TN) |
(P) unclassified |
| D01977 |
Gefitinib (JP18/USAN/INN); Iressa (TN) |
(P) unclassified |
| D02020 |
Mitobronitol (JAN/INN) |
(P) unclassified |
| D02063 |
Peplomycin sulfate (JP18/USAN); Pepleo (TN) |
(P) unclassified |
| D02106 |
Arsenic trioxide (JP18/USAN); Trisenox (TN) |
(P) unclassified |
| D02115 |
Methotrexate sodium; Trexall (TN); Rasuvo (TN) |
(P) unclassified |
| D02126 |
Primaquine phosphate (JAN/USP); Primaquine (TN) |
(P) unclassified |
| D02131 |
Tegafur and uracil; Uftoral (TN) |
(P) unclassified |
| D02165 |
Docetaxel (USP); Docetaxel hydrate (JP18); Docetaxel trihydrate; Taxotere (TN) |
(P) unclassified |
| D02166 |
Mitoxantrone hydrochloride (JAN/USP); Novantron (TN) |
(P) Target: TOP2A TOP2B |
| D02168 |
Topotecan hydrochloride (USAN); Nogitecan hydrochloride (JAN); Hycamtin (TN); Potactasol (TN) |
(P) unclassified |
| D02177 |
Bleomycin sulfate (JP18/USP); Blenoxane (TN) |
(P) unclassified |
| D02197 |
Vincristine sulfate (JP18/USP); VCR; Marqibo (TN); Oncovin (TN); Vincasar (TN); Vincrex (TN) |
(P) unclassified |
| D02214 |
Epirubicin hydrochloride (JP18/USP); EPI; Ellence (TN) |
(P) Target: TOP2A TOP2B |
| D02321 |
Amsacrine (USAN/INN); Amsidyl (TN) |
(P) Target: TOP2A TOP2B |
| D02368 |
Gemcitabine (USAN/INN) |
(P) unclassified |
| D02398 |
Estramustine phosphate sodium (USAN); Emcyt (TN) |
(P) unclassified |
| D02697 |
Valrubicin (USP/INN); Valstar (TN) |
(P) Target: TOP2A TOP2B |
| D02698 |
Teniposide (USP/INN); Vumon (TN) |
(P) Target: TOP2A TOP2B |
| D02714 |
Everolimus (JAN/USAN/INN); Afinitor (TN); Votubia (TN); Zortress (TN) |
(P) unclassified |
| D02756 |
Aclarubicin (USAN/INN); Aclacinomycin A; ACM |
(P) Target: TOP2A TOP2B |
| D02815 |
Alitretinoin (USAN); Panretin (TN) |
(P) unclassified |
| D02841 |
Altretamine (USP/INN); Hexalen (TN) |
(P) unclassified |
| D02908 |
Aminolevulinic acid hydrochloride (JAN/USAN); 5-Aminolevulinic acid hydrochloride; Levulan (TN); Ameluz (TN); Gleolan (TN) |
(P) unclassified |
| D02933 |
Anagrelide hydrochloride (USP); Agrylin (TN); Xagrid (TN) |
(P) unclassified |
| D02994 |
Rituximab (USAN/INN); Rituximab (genetical recombination) (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 2] (JAN); Rituximab-abbs; Rituximab-pvvr; Rituximab-arrx; Rituxan (TN); Riabni (TN); Truximab (TN) |
(P) unclassified |
| D02997 |
Asparaginase (USAN); L-Asparaginase (JAN); Asparaginase Erwinia chrysanthemi (USAN); Asparaginase erwinia chrysanthemi (recombinant)-rywn; Elspar (TN); Erwinaze (TN); Rylaze (TN) |
(P) unclassified |
| D03021 |
Azacitidine (JAN/USAN/INN); Vidaza (TN) |
(P) unclassified |
| D03046 |
Cytarabine ocfosfate hydrate (JAN); Cytarabine ocfosphate hydrate; Fosteabine sodium monohydrate; Starasid (TN) |
(P) unclassified |
| D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(P) unclassified |
| D03150 |
Bortezomib (JAN/USAN/INN); Velcade (TN) |
(P) unclassified |
| D03218 |
Axitinib (JAN/USAN); Inlyta (TN) |
(P) unclassified |
| D03225 |
Belotecan hydrochloride (USAN) |
(P) unclassified |
| D03229 |
Bleomycin hydrochloride (JP18); BLM; Bleo (TN) |
(P) unclassified |
| D03230 |
Insulin human (USP/INN); Insulin human (genetical recombination) (JP18); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN); Humulin (TN) |
(P) unclassified |
| D03250 |
Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP18); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN); Lantus (TN) |
(P) unclassified |
| D03252 |
Bosutinib (USAN) |
(P) unclassified |
| D03257 |
Trastuzumab (USAN/INN); Trastuzumab (genetical recombination) (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 1] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 2] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 3] (JAN); Trastuzumab-pkrb; Trastuzumab-anns; Trastuzumab-dkst; Trastuzumab-dttb; Trastuzumab-qyyp; Trastuzumab-anns; Herceptin (TN); Herzuma (TN); Kanjinti (TN); Ogivri (TN); Ontruzant (TN) |
(P) unclassified |
| D03259 |
Gemtuzumab ozogamicin (USAN); Gemtuzumab ozogamicin (genetical recombination) (JAN); Gemtuzumab (INN); Mylotarg (TN) |
(P) unclassified |
| D03327 |
Porfimer sodium (JAN/USAN/INN); Photofrin II; Photofrin (TN) |
(P) unclassified |
| D03455 |
Cetuximab (USAN/INN); Cetuximab (genetical recombination) (JAN); Erbitux (TN) |
(P) unclassified |
| D03546 |
Clofarabine (JAN/USAN/INN); Clolar (TN) |
(P) unclassified |
| D03637 |
Cytarabine hydrochloride (USAN) |
(P) unclassified |
| D03658 |
Dasatinib (JAN/INN) |
(P) unclassified |
| D03665 |
Decitabine (USAN/INN); Dacogen (TN) |
(P) unclassified |
| D03682 |
Denileukin diftitox (USAN/INN); Denileukin difitox (genetical recombination) (JAN); Ontak (TN); Remitoro (TN) |
(P) unclassified |
| D03828 |
Pemetrexed disodium (USAN); Alimta (TN) |
(P) unclassified |
| D03846 |
Dimethyl fumarate (JAN/USAN); Tecfidera (TN) |
(P) unclassified |
| D03899 |
Doxorubicin (USAN/INN); ADR; Adriblastina (TN) |
(P) Target: TOP2A TOP2B |
| D03958 |
Edrecolomab (USAN/INN); Panorex (TN) |
(P) unclassified |
| D03961 |
Efaproxiral (USAN/INN) |
(P) unclassified |
| D03962 |
Efaproxiral sodium (USAN) |
(P) unclassified |
| D04023 |
Erlotinib hydrochloride (JAN/USAN); Tarceva (TN) |
(P) unclassified |
| D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) unclassified |
| D04066 |
Estramustine (USAN/INN) |
(P) unclassified |
| D04107 |
Etoposide phosphate (USAN); Etopophos (TN) |
(P) Target: TOP2A TOP2B |
| D04187 |
Fingolimod hydrochloride (JAN/USAN); Gilenya (TN) |
(P) unclassified |
| D04197 |
Floxuridine (USP/INN); FUDR (TN) |
(P) unclassified |
| D04475 |
Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP18); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN); Insulin X 14; NovoRapid (TN); Novolog (TN) |
(P) unclassified |
| D04477 |
Insulin lispro (USP/INN); Insulin lispro (genetical recombination) (JAN); Insulin lispro (genetical recombination) [Insulin lispro Biosimilar 1] (JAN); Insulin lispro-aabc; Humalog (TN); Lyumjev (TN) |
(P) unclassified |
| D04539 |
Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN); Levemir (TN) |
(P) unclassified |
| D04540 |
Insulin glulisine (USAN/INN); Insulin glulisine (genetical recombination) (JAN); Apidra (TN) |
(P) unclassified |
| D04547 |
Insulin, isophane (USP); Isophane insulin human (genetical recombination) injectable aqueous suspension (JP18); Isophane insulin (aqueous suspension) (JAN); Humalog PEN (TN) |
(P) unclassified |
| D04603 |
Ipilimumab (USAN/INN); Ipilimumab (genetical recombination) (JAN); Yervoy (TN) |
(P) unclassified |
| D04645 |
Ixabepilone (JAN/USAN/INN); Ixempra (TN) |
(P) unclassified |
| D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(P) unclassified |
| D04862 |
Masoprocol (USAN/INN); meso-Nordihydroguaiaretic acid; Actinex (TN) |
(P) unclassified |
| D04872 |
Mechlorethamine hydrochloride (USP); Chlormethine hydrochloride; Mustargen (TN); Valchlor (TN) |
(P) unclassified |
| D04931 |
Mercaptopurine (INN); Mercaptopurine anhydrous; Purinethol (TN) |
(P) unclassified |
| D04988 |
Methyl aminolevulinate hydrochloride (USAN); Metvixia (TN) |
(P) unclassified |
| D05029 |
Midostaurin (JAN/USAN/INN); Rydapt (TN) |
(P) unclassified |
| D05134 |
Nelarabine (JAN/USAN/INN); Nelzarabine (USAN); Arranon (TN) |
(P) unclassified |
| D05216 |
Oblimersen sodium (USAN); Genasense (TN) |
(P) unclassified |
| D05333 |
Paclitaxel poliglumex (USAN/INN) |
(P) unclassified |
| D05350 |
Panitumumab (USAN/INN); Panitumumab (genetical recombination) (JAN); Vectibix (TN) |
(P) unclassified |
| D05380 |
Pazopanib hydrochloride (JAN/USAN); Votrient (TN) |
(P) unclassified |
| D05387 |
Pegaspargase (JAN/USAN/INN); Oncaspar (TN) |
(P) unclassified |
| D05446 |
Pertuzumab (USAN/INN); Pertuzumab (genetical recombination) (JAN); Perjeta (TN) |
(P) unclassified |
| D05522 |
Pixantrone (USAN/INN); Pixuvri (TN) |
(P) Target: TOP2A TOP2B |
| D05589 |
Pralatrexate (JAN/USAN/INN); 10-Propargyl-10-deazaaminopterin; Folotyn (TN) |
(P) unclassified |
| D05602 |
Prednimustine (USAN/INN) |
(P) unclassified |
| D05807 |
Satraplatin (USAN/INN) |
(P) unclassified |
| D05822 |
Semustine (USAN/INN) |
(P) unclassified |
| D05932 |
Streptozocin (JAN/USAN/INN); Streptozotocin; Zanosar (TN) |
(P) unclassified |
| D06066 |
Temoporfin (USAN/INN) |
(P) unclassified |
| D06067 |
Temozolomide (JP18/USAN/INN); Temodal (TN); Temodar (TN) |
(P) unclassified |
| D06068 |
Temsirolimus (JAN/USAN/INN); Torisel (TN) |
(P) unclassified |
| D06109 |
Thioguanine (USP); Thioguanine hydrate; Tabloid (TN); Thioguanine (TN) |
(P) unclassified |
| D06130 |
Tiazofurin (USAN); Tiazofurine (INN) |
(P) unclassified |
| D06199 |
Trabectedin (JAN/USAN/INN); Yondelis (TN) |
(P) unclassified |
| D06265 |
Uracil mustard (USAN); Uramustine (INN); Uracil mustard (TN) |
(P) unclassified |
| D06272 |
Sorafenib tosylate (USAN); Sorafenib tosilate (JAN); Nexavar (TN) |
(P) unclassified |
| D06304 |
Vindesine (USAN/INN) |
(P) unclassified |
| D06320 |
Vorinostat (JAN/USAN); Zolinza (TN) |
(P) unclassified |
| D06386 |
Zorubicin hydrochloride (USAN) |
(P) Target: TOP2A TOP2B |
| D06397 |
Estramustine phosphate sodium hydrate (JAN); Estramustine phosphate sodium monohydrate; Estracyt (TN); Emcyt (TN) |
(P) unclassified |
| D06399 |
Tegafur, gimeracil and oteracil potassium; Ts-1 (TN); Teysuno (TN) |
(P) unclassified |
| D06402 |
Sunitinib malate (JAN/USAN); Sutent (TN) |
(P) unclassified |
| D06407 |
Vandetanib (JAN/USAN/INN); Caprelsa (TN) |
(P) unclassified |
| D06409 |
Bevacizumab (USAN); Bevacizumab (genetical recombination) (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN); Bevacizumab-awwb; Bevacizumab-bvzr; Bevacizumab-maly; Bevacizumab-adcd; Avastin (TN); Alymsys (TN); Mvasi (TN); Vegzelma (TN); Zirabev (TN) |
(P) unclassified |
| D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) unclassified |
| D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) unclassified |
| D06503 |
Pemetrexed sodium hydrate (JAN); Pemetrexed disodium heptahydrate; Alimta (TN) |
(P) unclassified |
| D06637 |
Romidepsin (JAN/USAN/INN); Istodax (TN) |
(P) unclassified |
| D06657 |
Tremelimumab (USAN/INN); Tremelimumab (genetical recombination) (JAN); Tremelimumab-actl; CP 675206; Imjudo (TN) |
(P) unclassified |
| D07071 |
Mannosulfan (INN) |
(P) unclassified |
| D07085 |
Bendamustine hydrochloride (JAN/USAN); Treanda (TN); Ribomustin (TN) |
(P) unclassified |
| D07100 |
Amrubicin hydrochloride (JAN/USAN); Calsed (TN) |
(P) Target: TOP2A TOP2B |
| D07252 |
Trofosfamide (INN) |
(P) unclassified |
| D07253 |
Treosulfan (USAN/INN); Ovastat (TN) |
(P) unclassified |
| D07254 |
Triaziquone (INN) |
(P) unclassified |
| D07255 |
Fotemustine (INN/BAN); Muphoran (TN) |
(P) unclassified |
| D07256 |
Etoglucid (INN) |
(P) unclassified |
| D07257 |
Lonidamine (INN); Doridamina (TN) |
(P) unclassified |
| D07258 |
Mitoguazone (INN) |
(P) unclassified |
| D07455 |
Anagrelide (INN/BAN) |
(P) unclassified |
| D07472 |
Pemetrexed (INN); Alimta (TN); Pemetrexed (TN); Pemfexy (TN) |
(P) unclassified |
| D07501 |
Bendamustine (INN); Treanda (TN) |
(P) unclassified |
| D07535 |
Bleomycin (INN); BLM; Bleomycin Hexal (TN) |
(P) unclassified |
| D07567 |
Aminolevulinic acid |
(P) unclassified |
| D07671 |
Chlormethine (INN); Mechlorethamine |
(P) unclassified |
| D07760 |
Cyclophosphamide (INN); Cyclophosphamide (TN); Cytoxan (TN) |
(P) unclassified |
| D07772 |
Dacarbazine citrate |
(P) unclassified |
| D07776 |
Daunorubicin (INN); DM; DaunoXome (TN) |
(P) Target: TOP2A TOP2B |
| D07866 |
Docetaxel (JAN/INN); Docetaxel (TN); Taxotere (TN) |
(P) unclassified |
| D07883 |
Eflornithine (INN) |
(P) unclassified |
| D07901 |
Epirubicin (INN); Farmorubicin (TN) |
(P) Target: TOP2A TOP2B |
| D07907 |
Erlotinib (INN) |
(P) unclassified |
| D07966 |
Fludarabine (INN); Fluradosa (TN) |
(P) unclassified |
| D07974 |
Fluorouracil sodium salt; Fluorouracil (TN) |
(P) unclassified |
| D08024 |
Vosaroxin (USAN); Voreloxin |
(P) Target: TOP2A TOP2B |
| D08062 |
Idarubicin (INN); Zavedos (TN) |
(P) Target: TOP2A TOP2B |
| D08066 |
Imatinib (INN); Glamox (TN) |
(P) unclassified |
| D08080 |
Insulin injection, biphasic isophane (BAN); Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP18); Insulin Humacart (TN) |
(P) unclassified |
| D08086 |
Irinotecan (INN); Biotecan (TN) |
(P) unclassified |
| D08108 |
Lapatinib (INN) |
(P) unclassified |
| D08173 |
Melphalan hydrochloride; Alkeran (TN); Evomela (TN) |
(P) unclassified |
| D08204 |
Methyl aminolevulinate |
(P) unclassified |
| D08224 |
Mitoxantrone (INN); Misostol (TN) |
(P) Target: TOP2A TOP2B |
| D08276 |
Nimustine (INN) |
(P) unclassified |
| D08290 |
Oblimersen (INN) |
(P) unclassified |
| D08386 |
Pirarubicin hydrochloride; Pinorubin (TN); Therarubicin (TN) |
(P) Target: TOP2A TOP2B |
| D08423 |
Procarbazine (INN) |
(P) unclassified |
| D08524 |
Sorafenib (USAN/INN) |
(P) unclassified |
| D08552 |
Sunitinib (INN) |
(P) unclassified |
| D08603 |
Tioguanine (INN); Lanvis (TN) |
(P) unclassified |
| D08618 |
Topotecan (BAN); Hycamtin (TN) |
(P) unclassified |
| D08675 |
Vinblastine (INN); Vinblastina (TN) |
(P) unclassified |
| D08679 |
Vincristine (INN); Tecnocris (TN) |
(P) unclassified |
| D08680 |
Vinorelbine (INN); Navelbine (TN) |
(P) unclassified |
| D08854 |
Amrubicin (USAN/INN) |
(P) Target: TOP2A TOP2B |
| D08870 |
Belinostat (USAN/INN); Beleodaq (TN) |
(P) unclassified |
| D08880 |
Carfilzomib (JAN/USAN/INN); Kyprolis (TN) |
(P) unclassified |
| D08881 |
Cediranib (USAN/INN) |
(P) unclassified |
| D08883 |
Cediranib maleate (JAN/USAN) |
(P) unclassified |
| D08900 |
Ridaforolimus (JAN/USAN/INN); Deforolimus |
(P) unclassified |
| D08914 |
Eribulin mesylate (USAN); Eribulin mesilate (JAN); Halaven (TN) |
(P) unclassified |
| D08933 |
Inotuzumab ozogamicin (USAN/INN); Inotuzumab ozogamicin (genetical recombination) (JAN); Besponsa (TN) |
(P) unclassified |
| D08950 |
Neratinib (USAN/INN) |
(P) unclassified |
| D08953 |
Nilotinib (USAN/INN) |
(P) unclassified |
| D08956 |
Omacetaxine mepesuccinate (USAN); Homoharringtonine; Synribo (TN) |
(P) unclassified |
| D09032 |
Vinflunine ditartrate (USAN); Javlor (TN) |
(P) unclassified |
| D09197 |
Valsartan and hydrochlorothiazide (JP18); Co-dio (TN) |
(P) unclassified |
| D09207 |
Catumaxomab (INN); Removab (TN) |
(P) unclassified |
| D09217 |
Sitimagene ceradenovec (INN) |
(P) unclassified |
| D09314 |
Ofatumumab (USAN/INN); Ofatumumab (genetical recombination) (JAN); Arzerra (TN); Kesimpta (TN) |
(P) unclassified |
| D09321 |
Obinutuzumab (USAN/INN); Obinutuzumab (genetical recombination) (JAN); Gazyva (TN) |
(P) unclassified |
| D09325 |
Blinatumomab (USAN/INN); Blinatumomab (genetical recombination) (JAN); Blincyto (TN) |
(P) unclassified |
| D09337 |
Elotuzumab (USAN); Elotuzumab (genetical recombination) (JAN); Empliciti (TN) |
(P) unclassified |
| D09338 |
Entinostat (JAN/USAN/INN) |
(P) unclassified |
| D09371 |
Ramucirumab (USAN); Ramucirumab (genetical recombination) (JAN); Cyramza (TN) |
(P) unclassified |
| D09574 |
Aflibercept (USAN/INN); Aflibercept (genetical recombination) (JAN); Aflibercept (genetical recombination) [Aflibercept biosimilar 1] (JAN); Ziv-aflibercept; Eylea (TN); Zaltrap (TN) |
(P) unclassified |
| D09587 |
Brentuximab vedotin (USAN/INN); Brentuximab vedotin (genetical recombination) (JAN); Adcetris (TN) |
(P) unclassified |
| D09629 |
Imetelstat (USAN/INN) |
(P) unclassified |
| D09630 |
Imetelstat sodium (USAN) |
(P) unclassified |
| D09654 |
Pixantrone dimaleate (USAN); Pixuvri (TN) |
(P) Target: TOP2A TOP2B |
| D09666 |
Selumetinib (USAN/INN) |
(P) unclassified |
| D09683 |
Tivozanib (USAN/INN) |
(P) unclassified |
| D09692 |
Veliparib (JAN/USAN/INN) |
(P) unclassified |
| D09724 |
Afatinib (USAN/INN) |
(P) unclassified |
| D09727 |
Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN); Tresiba (TN) |
(P) unclassified |
| D09728 |
Bosutinib hydrate (JAN); Bosutinib monohydrate; Bosulif (TN) |
(P) unclassified |
| D09730 |
Olaparib (JAN/USAN/INN); Lynparza (TN) |
(P) unclassified |
| D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) unclassified |
| D09733 |
Afatinib dimaleate (USAN); Afatinib maleate (JAN); Gilotrif (TN); Giotrif (TN) |
(P) unclassified |
| D09755 |
Cabazitaxel (USAN/INN); Jevtana (TN) |
(P) unclassified |
| D09761 |
Mogamulizumab (USAN); Mogamulizumab (genetical recombination) (JAN); Mogamulizumab-kpkc; Poteligeo (TN) |
(P) unclassified |
| D09883 |
Dacomitinib (INN) |
(P) unclassified |
| D09919 |
Lenvatinib (USAN/INN) |
(P) unclassified |
| D09920 |
Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN); Lenvima (TN) |
(P) unclassified |
| D09932 |
Moxetumomab pasudotox (USAN/INN); Moxetumomab pasudotox-tdfk; Lumoxiti (TN) |
(P) unclassified |
| D09935 |
Navitoclax (JAN/USAN/INN) |
(P) unclassified |
| D09936 |
Navitoclax dihydrochloride (USAN) |
(P) unclassified |
| D09939 |
Olaratumab (USAN/INN); Olaratumab (genetical recombination) (JAN); Lartruvo (TN) |
(P) unclassified |
| D09950 |
Ponatinib (USAN/INN) |
(P) unclassified |
| D09951 |
Ponatinib hydrochloride (JAN/USAN); Iclusig (TN) |
(P) unclassified |
| D09955 |
Quizartinib (USAN/INN) |
(P) unclassified |
| D09956 |
Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN); Vanflyta (TN) |
(P) unclassified |
| D09959 |
Ruxolitinib (USAN/INN) |
(P) unclassified |
| D09960 |
Ruxolitinib phosphate (JAN/USAN); Jakafi (TN); Jakavi (TN); Opzelura (TN) |
(P) unclassified |
| D09966 |
Talimogene laherparepvec (USAN); Talminogene laherparepvec; Imlygic (TN); Oncovex (TN) |
(P) unclassified |
| D09980 |
Trastuzumab emtansine (USAN/INN); Trastuzumab emtansine (genetical recombination) (JAN); Ado-trastuzumab emtansine; Kadcyla (TN) |
(P) unclassified |
| D09992 |
Vismodegib (USAN/INN); Erivedge (TN) |
(P) unclassified |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) unclassified |
| D10018 |
Necitumumab (USAN/INN); Necitumumab (genetical recombination) (JAN); Portrazza (TN) |
(P) unclassified |
| D10019 |
Panobinostat lactate (JAN); Farydak (TN) |
(P) unclassified |
| D10024 |
Selumetinib sulfate (JAN/USAN); Koselugo (TN) |
(P) unclassified |
| D10062 |
Cabozantinib (USAN); Cabometyx (TN); Cometriq (TN) |
(P) unclassified |
| D10064 |
Dabrafenib (USAN) |
(P) unclassified |
| D10079 |
Rucaparib (USAN/INN) |
(P) unclassified |
| D10095 |
Cabozantinib s-malate (USAN); Cabozantinib malate (JAN); Cometriq (TN); Cabometyx (TN) |
(P) unclassified |
| D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) unclassified |
| D10119 |
Sonidegib (USAN/INN); Erismodegib |
(P) unclassified |
| D10130 |
Ixazomib (USAN) |
(P) unclassified |
| D10131 |
Ixazomib citrate (JAN/USAN); Ninlaro (TN) |
(P) unclassified |
| D10137 |
Regorafenib hydrate (JAN); Stivarga (TN) |
(P) unclassified |
| D10138 |
Regorafenib (USAN/INN); Stivarga (TN) |
(P) unclassified |
| D10140 |
Niraparib (USAN) |
(P) unclassified |
| D10157 |
Rucaparib phosphate (USAN) |
(P) unclassified |
| D10175 |
Trametinib (USAN) |
(P) unclassified |
| D10176 |
Trametinib dimethyl sulfoxide (JAN/USAN); Mekinist (TN); Spexotras (TN) |
(P) unclassified |
| D10190 |
Tivozanib hydrochloride (USAN); Tivozanib hydrochloride monohydrate; Fotivda (TN) |
(P) unclassified |
| D10222 |
Gemcitabine elaidate (USAN/INN) |
(P) unclassified |
| D10223 |
Ibrutinib (JAN/USAN); Imbruvica (TN) |
(P) unclassified |
| D10229 |
Masitinib (INN) |
(P) unclassified |
| D10255 |
Anagrelide hydrochloride hydrate (JAN); Anagrelide hydrochloride monohydrate; Agrylin (TN) |
(P) unclassified |
| D10315 |
Momelotinib (USAN/INN) |
(P) unclassified |
| D10316 |
Nivolumab (USAN/INN); Nivolumab (genetical recombination) (JAN); Opdivo (TN) |
(P) unclassified |
| D10319 |
Panobinostat (USAN/INN); Farydak (TN) |
(P) unclassified |
| D10358 |
Momelotinib dihydrochloride (USAN) |
(P) unclassified |
| D10367 |
Etirinotecan pegol (USAN/INN) |
(P) unclassified |
| D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
| D10396 |
Nintedanib esylate (USAN); Nintedanib ethanesulfonate (JAN); Ofev (TN) |
(P) unclassified |
| D10405 |
Cobimetinib (USAN/INN) |
(P) unclassified |
| D10422 |
Etirinotecan pegol tetrahydrochloride (USAN) |
(P) unclassified |
| D10427 |
Etirinotecan pegol tetratriflutate (USAN) |
(P) unclassified |
| D10434 |
Vintafolide (USAN/INN) |
(P) unclassified |
| D10446 |
Margetuximab (USAN/INN); Margetuximab-cmkb; Margenza (TN) |
(P) unclassified |
| D10450 |
Alectinib hydrochloride (JAN); Alecensa (TN) |
(P) unclassified |
| D10452 |
Cabazitaxel acetonate (JAN); Cabazitaxel acetone; Jevtana (TN) |
(P) unclassified |
| D10481 |
Nintedanib (USAN/INN); Ofev (TN) |
(P) unclassified |
| D10514 |
Dacomitinib (USAN); Dacomitinib hydrate (JAN); Vizimpro (TN) |
(P) unclassified |
| D10517 |
Crisantaspase (JAN/INN); Enrylaze (TN); Erwinase (TN) |
(P) unclassified |
| D10526 |
Trifluridine and tipiracil hydrochloride; Lonsurf (TN) |
(P) unclassified |
| D10542 |
Alectinib (USAN/INN) |
(P) unclassified |
| D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) unclassified |
| D10555 |
Duvelisib (USAN/INN) |
(P) unclassified |
| D10559 |
Dinutuximab (USAN/INN); Dinutuximab (genetical recombination) (JAN); Unituxin (TN) |
(P) unclassified |
| D10560 |
Idelalisib (JAN/USAN/INN); Zydelig (TN) |
(P) unclassified |
| D10570 |
Insulin degludec (genetical recombination) and insulin aspart (genetical recombination); Ryzodeg (TN) |
(P) unclassified |
| D10574 |
Pembrolizumab (USAN); Pembrolizumab (genetical recombination) (JAN); Keytruda (TN) |
(P) unclassified |
| D10596 |
Pemetrexed sodium hemipentahydrate (JAN); Pemetrexed disodium hemipentahydrate; Pemetrexed accord (TN) |
(P) unclassified |
| D10604 |
Binimetinib (JAN/USAN/INN); Mektovi (TN) |
(P) unclassified |
| D10615 |
Cobimetinib fumarate (USAN); Cobimetinib hemifumarate; Cotellic (TN) |
(P) unclassified |
| D10630 |
Fedratinib (USAN/INN) |
(P) unclassified |
| D10636 |
Glasdegib (USAN/INN) |
(P) unclassified |
| D10642 |
Irinotecan sucrosofate (USAN) |
(P) unclassified |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) unclassified |
| D10652 |
Palbociclib isethionate (USAN) |
(P) unclassified |
| D10679 |
Venetoclax (JAN/USAN/INN); Venclexta (TN) |
(P) unclassified |
| D10688 |
Abemaciclib (JAN/USAN/INN); Verzenio (TN) |
(P) unclassified |
| D10696 |
Capmatinib (USAN/INN) |
(P) unclassified |
| D10709 |
Gilteritinib (USAN/INN) |
(P) unclassified |
| D10729 |
Sonidegib phosphate (USAN); Sonidegib diphosphate; Odomzo (TN) |
(P) unclassified |
| D10732 |
Talazoparib (USAN/INN) |
(P) unclassified |
| D10733 |
Talazoparib tosylate (USAN); Talazoparib tosilate (JAN); Talzenna (TN) |
(P) unclassified |
| D10761 |
Polatuzumab vedotin (USAN); Polatuzumab vedotin (genetical recombination) (JAN); Polatuzumab vedotin-piiq; Polivy (TN) |
(P) unclassified |
| D10766 |
Osimertinib mesylate (USAN); Osimertinib mesilate (JAN); Tagrisso (TN) |
(P) unclassified |
| D10773 |
Atezolizumab (USAN/INN); Atezolizumab (genetical recombination) (JAN); Tecentriq (TN) |
(P) unclassified |
| D10777 |
Daratumumab (USAN); Daratumumab (genetical recombination) (JAN); Darzalex (TN) |
(P) unclassified |
| D10787 |
Daunorubicin citrate; Daunoxome (TN) |
(P) Target: TOP2A TOP2B |
| D10797 |
Copanlisib hydrochloride (USAN) |
(P) unclassified |
| D10798 |
Copanlisib hydrochloride hydrate (JAN); Aliqopa (TN) |
(P) unclassified |
| D10800 |
Gilteritinib fumarate (JAN/USAN); Xospata (TN) |
(P) unclassified |
| D10808 |
Durvalumab (USAN/INN); Durvalumab (genetical recombination) (JAN); Imfinzi (TN) |
(P) unclassified |
| D10817 |
Avelumab (USAN/INN); Avelumab (genetical recombination) (JAN); Bavencio (TN) |
(P) unclassified |
| D10858 |
Rociletinib (USAN/INN) |
(P) unclassified |
| D10859 |
Olmutinib (USAN/INN) |
(P) unclassified |
| D10866 |
Brigatinib (JAN/USAN); Alunbrig (TN) |
(P) unclassified |
| D10867 |
Copanlisib (USAN/INN) |
(P) unclassified |
| D10883 |
Ribociclib (USAN/INN) |
(P) unclassified |
| D10889 |
Momelotinib hydrochloride hydrate (JAN); Momelotinib dihydrochloride monohydrate; Ojjaara (TN); Omjjara (TN) |
(P) unclassified |
| D10891 |
Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN); Tabrecta (TN) |
(P) unclassified |
| D10893 |
Acalabrutinib (JAN/USAN/INN); Calquence (TN) |
(P) unclassified |
| D10898 |
Neratinib maleate; Nerlynx (TN) |
(P) unclassified |
| D10901 |
Enasidenib (USAN/INN) |
(P) unclassified |
| D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) unclassified |
| D10927 |
Erdafitinib (JAN/USAN/INN); Balversa (TN) |
(P) unclassified |
| D10954 |
Mirvetuximab soravtansine (USAN/INN); Mirvetuximab soravtansine-gynx; Elahere (TN) |
(P) unclassified |
| D10973 |
Padeliporfin (USAN/INN) |
(P) unclassified |
| D10979 |
Ribociclib succinate (USAN); Kisqali (TN) |
(P) unclassified |
| D10982 |
Rucaparib camsylate (USAN); Rubraca (TN) |
(P) unclassified |
| D10985 |
Sacituzumab govitecan (USAN/INN); Sacituzumab govitecan (genetical recombination) (JAN); Sacituzumab govitecan-hziy; Trodelvy (TN) |
(P) unclassified |
| D11011 |
Alpelisib (JAN/USAN/INN); Piqray (TN) |
(P) unclassified |
| D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) unclassified |
| D11032 |
Plitidepsin (INN) |
(P) unclassified |
| D11034 |
Insulin glargine and lixisenatide; Insulin glargine (genetical recombination) and lixisenatide; Soliqua (TN) |
(P) unclassified |
| D11044 |
Enasidenib mesylate (USAN); Idhifa (TN) |
(P) unclassified |
| D11049 |
Epacadostat (JAN/USAN/INN) |
(P) unclassified |
| D11050 |
Isatuximab (USAN/INN); Isatuximab (genetical recombination) (JAN); Isatuximab-irfc; Sarclisa (TN) |
(P) unclassified |
| D11053 |
Encorafenib (JAN/USAN/INN); Braftovi (TN) |
(P) unclassified |
| D11072 |
Siponimod fumarate (USAN); Siponimod fumaric acid (JAN); Mayzent (TN) |
(P) unclassified |
| D11073 |
Tepotinib hydrochloride (USAN); Tepotinib hydrochloride hydrate (JAN); Tepmetko (TN) |
(P) unclassified |
| D11090 |
Ivosidenib (JAN/USAN/INN); Tibsovo (TN) |
(P) unclassified |
| D11107 |
Glasdegib maleate (JAN); Daurismo (TN) |
(P) unclassified |
| D11108 |
Cemiplimab (USAN); Cemiplimab (genetical recombination) (JAN); Cemiplimab-rwlc; Libtayo (TN) |
(P) unclassified |
| D11115 |
Olmutinib hydrochloride (USAN) |
(P) unclassified |
| D11137 |
Larotrectinib (USAN/INN) |
(P) unclassified |
| D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
| D11140 |
Sitravatinib (USAN/INN) |
(P) unclassified |
| D11141 |
Tucatinib (USAN/INN); Tukysa (TN) |
(P) unclassified |
| D11144 |
Axicabtagene ciloleucel (USAN); Yescarta (TN) |
(P) unclassified |
| D11146 |
Tabelecleucel (USAN); Ebvallo (TN) |
(P) unclassified |
| D11222 |
Selinexor (USAN/INN); Xpovio (TN) |
(P) unclassified |
| D11251 |
Icotinib |
(P) unclassified |
| D11253 |
Bermekimab (USAN) |
(P) unclassified |
| D11270 |
Pexidartinib (USAN/INN) |
(P) unclassified |
| D11271 |
Pexidartinib hydrochloride (JAN/USAN); Turalio (TN) |
(P) unclassified |
| D11279 |
Avapritinib (USAN/INN); Ayvakit (TN); Ayvakyt (TN) |
(P) unclassified |
| D11296 |
Fedratinib hydrochloride (USAN); Fedratinib hydrochloride hydrate (JAN); Fedratinib dihydrochloride monohydrate; Inrebic (TN) |
(P) unclassified |
| D11322 |
Umbralisib (USAN/INN) |
(P) unclassified |
| D11323 |
Umbralisib tosylate (USAN); Ukoniq (TN) |
(P) unclassified |
| D11338 |
Loncastuximab tesirine (USAN); Loncastuximab tesirine (genetical recombination) (JAN); Loncastuximab tesirine-lpyl; Zynlonta (TN) |
(P) unclassified |
| D11353 |
Ripretinib (USAN); Qinlock (TN) |
(P) unclassified |
| D11358 |
Tagraxofusp (USAN/INN); Tagraxofusp-erzs; Elzonris (TN) |
(P) unclassified |
| D11366 |
Dostarlimab (USAN); Dostarlimab-gxly; Jemperli (TN) |
(P) unclassified |
| D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
| D11371 |
Capivasertib (JAN/USAN); Truqap (TN) |
(P) unclassified |
| D11375 |
Trastuzumab duocarmazine (USAN/INN) |
(P) unclassified |
| D11386 |
Tisagenlecleucel-T (USAN); Tisagenlecleucel (INN); Kymriah (TN) |
(P) unclassified |
| D11390 |
Daunorubicin and cytarabine; Vyxeos (TN) |
(P) unclassified |
| D11393 |
Rituximab and hyaluronidase; Rituxan hycela (TN) |
(P) unclassified |
| D11403 |
Asciminib (USAN/INN) |
(P) unclassified |
| D11404 |
Asciminib hydrochloride (JAN/USAN); Scemblix (TN) |
(P) unclassified |
| D11416 |
Naxitamab (USAN); Naxitamab-gqgk; Danyelza (TN) |
(P) unclassified |
| D11417 |
Pemigatinib (JAN/USAN/INN); Pemazyre (TN) |
(P) unclassified |
| D11422 |
Zanubrutinib (JAN/USAN/INN); Brukinsa (TN) |
(P) unclassified |
| D11426 |
Pamiparib (USAN/INN) |
(P) unclassified |
| D11437 |
Parsaclisib (USAN/INN) |
(P) unclassified |
| D11444 |
Tazemetostat (USAN/INN) |
(P) unclassified |
| D11463 |
Mosunetuzumab (USAN/INN); Mosunetuzumab (genetical recombination) (JAN); Mosunetuzumab-axgb; Lunsumio (TN) |
(P) unclassified |
| D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
| D11487 |
Tislelizumab (USAN/INN); Tislelizumab (genetical recombination) (JAN); Tislelizumab-jsgr; Tevimbra (TN) |
(P) unclassified |
| D11506 |
Parsaclisib hydrochloride (JAN/USAN) |
(P) unclassified |
| D11525 |
Enfortumab vedotin (USAN); Enfortumab vedotin (genetical recombination) (JAN); Enfortumab vedotin-ejfv; Padcev (TN) |
(P) unclassified |
| D11529 |
Trastuzumab deruxtecan (USAN/INN); Trastuzumab deruxtecan (genetical recombination) (JAN); Fam-trastuzumab deruxtecan-nxki; Enhertu (TN) |
(P) unclassified |
| D11541 |
Sitravatinib malate (USAN) |
(P) unclassified |
| D11556 |
Idecabtagene vicleucel (USAN); Abecma (TN) |
(P) unclassified |
| D11560 |
Trastuzumab and hyaluronidase; Trastuzumab and hyaluronidase-oysk; Herceptin hylecta (TN) |
(P) unclassified |
| D11567 |
Insulin degludec and liraglutide; Xultophy (TN) |
(P) unclassified |
| D11589 |
Infigratinib (USAN/INN) |
(P) unclassified |
| D11595 |
Belantamab mafodotin (USAN); Belantamab mafodotin (genetical recombination) (JAN); Belantamab mafodotin-blmf; Blenrep (TN) |
(P) unclassified |
| D11601 |
Tafasitamab (USAN/INN); Tafasitamab (genetical recombination) (JAN); Tafasitamab-cxix; Monjuvi (TN); Minjuvi (TN) |
(P) unclassified |
| D11611 |
Infigratinib phosphate (USAN); Truseltiq (TN) |
(P) unclassified |
| D11644 |
Lurbinectedin (USAN/INN); Zepzelca (TN) |
(P) unclassified |
| D11658 |
Duvelisib hydrate (JAN); Copiktra (TN) |
(P) unclassified |
| D11661 |
Bendamustine hydrochloride hydrate (JAN); Bendamustine hydrochloride monohydrate; Treakisym (TN) |
(P) unclassified |
| D11712 |
Pralsetinib (USAN/INN); Gavreto (TN) |
(P) unclassified |
| D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) unclassified |
| D11717 |
Tepotinib (USAN/INN) |
(P) unclassified |
| D11720 |
Acalabrutinib maleate (USAN) |
(P) unclassified |
| D11725 |
Futibatinib (JAN/USAN/INN); Lytgobi (TN) |
(P) unclassified |
| D11768 |
Pacritinib (USAN/INN); Vonjo (TN) |
(P) unclassified |
| D11814 |
Tisotumab vedotin (USAN/INN); Tisotumab vedotin (genetical recombination) (JAN); Tisotumab vedotin-tftv; Tivdak (TN) |
(P) unclassified |
| D11827 |
Retifanlimab (USAN); Retifanlimab-dlwr; Zynyz (TN) |
(P) unclassified |
| D11833 |
Glofitamab (USAN/INN); Glofitamab-gxbm; Columvi (TN) |
(P) unclassified |
| D11848 |
Decitabine and cedazuridine; Inqovi (TN) |
(P) unclassified |
| D11865 |
Melphalan flufenamide (USAN/INN) |
(P) unclassified |
| D11870 |
Melphalan flufenamide hydrochloride (USAN); Pepaxto (TN); Pepaxti (TN) |
(P) unclassified |
| D11880 |
Brexucabtagene autoleucel (USAN); Tecartus (TN) |
(P) unclassified |
| D11885 |
Surufatinib (USAN/INN) |
(P) unclassified |
| D11894 |
Amivantamab (USAN/INN); Amivantamab (genetical recombination) (JAN); Amivantamab-vmjw; Rybrevant (TN) |
(P) unclassified |
| D11895 |
Niraparib tosilate hydrate (JAN); Niraparib tosylate monohydrate; Zejula (TN) |
(P) unclassified |
| D11913 |
Oportuzumab monatox (USAN) |
(P) unclassified |
| D11934 |
Pertuzumab, trastuzumab and hyaluronidase; Pertuzumab (genetical recombination), trastuzumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination); Pertuzumab, trastuzumab and hyaluronidase-zzxf; Phesgo (TN) |
(P) unclassified |
| D11954 |
Belzutifan (JAN/USAN/INN); Welireg (TN) |
(P) unclassified |
| D11967 |
Daratumumab and hyaluronidase; Daratumumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination); Daratumumab and hyaluronidase-fihj; Darzalex faspro (TN); Darzquro (TN) |
(P) unclassified |
| D11969 |
Mobocertinib succinate (JAN); Exkivity (TN) |
(P) unclassified |
| D11977 |
Fruquintinib (JAN/USAN); Fruzaqla (TN) |
(P) unclassified |
| D11980 |
Lazertinib (USAN) |
(P) unclassified |
| D11990 |
Lisocabtagene maraleucel (USAN/INN); Breyanzi (TN) |
(P) unclassified |
| D12001 |
Mobocertinib (USAN/INN) |
(P) unclassified |
| D12050 |
Pirtobrutinib (JAN/USAN); Jaypirca (TN) |
(P) unclassified |
| D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
| D12160 |
Orelabrutinib (USAN/INN) |
(P) unclassified |
| D12164 |
Sabatolimab (USAN/INN); Sabatolimab (genetical recombination) (JAN) |
(P) unclassified |
| D12177 |
Teclistamab (USAN/INN); Teclistamab (genetical recombination) (JAN); Teclistamab-cqyv; Tecvayli (TN) |
(P) unclassified |
| D12180 |
Talquetamab (USAN/INN); Talquetamab-tgvs; Talvey (TN) |
(P) unclassified |
| D12202 |
Toripalimab (USAN/INN); Toripalimab-tpzi; Loqtorzi (TN) |
(P) unclassified |
| D12245 |
Lazertinib mesilate hydrate (JAN) |
(P) unclassified |
| D12258 |
Aumolertinib (USAN/INN) |
(P) unclassified |
| D12259 |
Aumolertinib mesylate (USAN) |
(P) unclassified |
| D12296 |
Tebentafusp (USAN/INN); Tebentafusp-tebn; Kimmtrak (TN) |
(P) unclassified |
| D12301 |
Adagrasib (USAN/INN); Krazati (TN) |
(P) unclassified |
| D12311 |
Bortezomib hydrate (JAN) |
(P) unclassified |
| D12315 |
Ciltacabtagene autoleucel (USAN/INN); Carvykti (TN); Carvykti (TN) |
(P) unclassified |
| D12334 |
Nivolumab and relatlimab; Nivolumab and relatlimab-rmbw; Opdualag (TN) |
(P) unclassified |
| D12353 |
Ensitrelvir fumarate (USAN); Ensitrelvir fumaric acid (JAN); Xocova (TN) |
(P) unclassified |
| D12354 |
Pralsetinib hydrate (JAN) |
(P) unclassified |
| D12368 |
Epcoritamab (USAN/INN); Epcoritamab (genetical recombination) (JAN); Epcoritamab-bysp; Epkinly (TN); Tepkinly (TN) |
(P) unclassified |
| D12442 |
Tucatinib ethanolate (JAN); Tucatinib hemiethanolate |
(P) unclassified |
| D12444 |
Nilotinib hydrochloride dihydrate (JAN) |
(P) unclassified |
| D12531 |
Nadofaragene firadenovec (USAN/INN); Nadofaragene firadenovec-vncg; Adstiladrin (TN) |
(P) unclassified |
| D12609 |
Dasatinib laurylsulfate (USAN) |
(P) unclassified |
| D12653 |
Niraparib and abiraterone; Akeega (TN) |
(P) unclassified |
| D12704 |
Acalabrutinib maleate hydrate (JAN); Acalabrutinib maleate monohydrate |
(P) unclassified |
| D12750 |
Sugemalimab (INN) |
(P) unclassified |
| D12751 |
Serplulimab (INN) |
(P) unclassified |
| D12833 |
Lifileucel (USAN/INN); Amtagvi (TN) |
(P) unclassified |
| D12854 |
Nilotinib laurylsulfate (USAN) |
(P) unclassified |
